Abstract
The transcription rate of interleukin-6 (IL-6) can be reduced by the C-allele of a polymorphism (rs1800795) located in the 5′-flanking region of the IL-6 gene (NM_000600), and IL-6 plasma levels increase with age. We assembled an elderly Italian population [“The Treviso Longeva (Trelong) study”, age range 70–106 years, n = 668 subjects] and assessed rs1800795 genotype and plasma IL-6 concentrations. The rs1800795 genotype was also assessed in an independent Italian study (“Milan” study, age range 70–96, n = 245 subjects). To verify an age- or sex-specific effect of rs1800795 genotype we compared people younger (70–85) and older (85+) than 85 years of age. We found a significant reduction in the frequency of rs1800795 C/C genotype in 85+ men from the Trelong study, while in the Milan study this data did not reach significance. However, considering the two studies together, the frequency of the rs1800795 C/C genotype was significantly lower in 85+ than in 70–85 males (4.0% and 10.7%, respectively), while it remained unchanged in females. As for IL-6 plasma levels, after a multivariate analysis to control for confounders, a correlation between age and plasma IL-6 concentrations was revealed (P < 0.0001). An increase in circulating IL-6 levels in the entire 85+ group compared to the 70–85 group (P < 0.05, Tukey′s test) was also noticed. We suggest a sex-specific pattern for genetic variability linked to inflammatory response and longevity, consistent with the age-related increase in IL-6.
![](http://media.springernature.com/m312/springer-static/image/art%3A10.1007%2Fs11357-009-9092-5/MediaObjects/11357_2009_9092_Fig1_HTML.gif)
![](http://media.springernature.com/m312/springer-static/image/art%3A10.1007%2Fs11357-009-9092-5/MediaObjects/11357_2009_9092_Fig2_HTML.gif)
Similar content being viewed by others
References
Antebi A (2007) Genetics of aging in Caenorhabditis elegans. PLoS Genet 3:1565–1571. doi:10.1371/journal.pgen.0030129
Barbieri M, Bonafè M, Rizzo MR, Ragno E, Olivieri F, Marchegiani F, Franceschi C, Paolisso G (2004) Gender specific association of genetic variation in peroxisome proliferator-activated receptor (PPAR) gamma-2 with longevity. Exp Gerontol 39:1095–1100. doi:10.1016/j.exger.2004.03.034
Bonafè M, Olivieri F, Cavallone L, Giovagnetti S, Mayegiani F, Cardelli M, Pieri C, Marra M, Antonicelli R, Lisa R, Rizzo MR, Paolisso G, Monti D, Franceschi C (2001) A gender-dependent genetic predisposition to produce high levels of IL-6 is detrimental for longevity. Eur J Immunol 31:2357–2361. doi:10.1002/1521-4141(200108) 31:8 < 2357::AID-IMMU2357 > 3.0.CO;2-X
Capurso C, Solfrizzi V, D′Introno A, Colacicco AM, Capurso SA, Semeraro C, Capurso A, Panza F (2004) Interleukin 6-174 G/C promoter gene polymorphism in centenarians: no evidence of association with human longevity or interaction with apolipoprotein E alleles. Exp Gerontol 39:1109–1114. doi:10.1016/j.exger.2004.03.037
Caruso C, Lio D, Cavallone L, Franceschi C (2004) Aging, longevity, inflammation, and cancer. Ann N Y Acad Sci 1028:1–13. doi:10.1196/annals.1322.001
Cederholm T, Persson M, Andersson P, Stenvinkel P, Nordfors L, Madden J, Vedin I, Wretlind B, Grimble RF, Palmblad J (2007) Polymorphisms in cytokine genes influence long-term survival differently in elderly male and female patients. J Intern Med 262:215–223. doi:10.1111/j.1365-2796.2007.01803.x
Christiansen L, Bathum L, Andersen-Ranberg K, Jeune B, Christensen K (2004) Modest implication of interleukin-6 promoter polymorphisms in longevity. Mech Ageing Dev 125:391–395. doi:10.1016/j.mad.2004.03.004
Colinet B, Jacot W, Bertrand D, Lacombe S, Bozonnat MC, Daures JP, Pujol JL (2005) A new simplified comorbidity score as a prognostic factor in non-small-cell lung cancer patients: description and comparison with the Charlson′s index. Br J Cancer 93:1098–1105. doi:10.1038/sj.bjc.6602836
Fishman D, Faulds G, Jeffery R, Mohamed-Ali V, Yudkin JS, Humphries S, Woo P (1998) The effect of novel polymorphisms in the interleukin-6 (IL-6) gene on IL-6 transcription and plasma IL-6 levels, and an association with systemic-onset juvenile chronic arthritis. J Clin Invest 102:1369–1376. doi:10.1172/JCI2629
Franceschi C, Bonafè M, Valensin S, Olivieri F, De Luca M, Ottaviani E, De Benedictis G (2000a) Inflamm-aging. An evolutionary perspective on immunosenescence. Ann N Y Acad Sci 908:244–254
Franceschi C, Motta L, Valensin S, Rapisarda R, Franzone A, Berardelli M, Motta M, Monti D, Bonafè M, Ferrucci L, Deiana L, Pes GM, Carru C, Desole MS, Barbi C, Sartoni G, Gemelli C, Lescai F, Olivieri F, Marchegiani F, Cardelli M, Cavallone L, Gueresi P, Cossarizza A, Troiano L, Pini G, Sansoni P, Passeri G, Lisa R, Spazzafumo L, Amadio L, Giunta S, Stecconi R, Morresi R, Viticchi C, Mattace R, De Benedictis G, Baggio G (2000b) Do men and women follow different trajectories to reach extreme longevity? Italian Multicenter Study on Centenarians (IMUSCE) Aging (Milano) 12:77–84
Gallucci M, Amici GP, Ongaro F, Gajo GB, De Angeli S, Forloni GL, Albani D, Prato F, Polito L, Zanardo A, Regini C (2007a) Associations of the plasma interleukin 6 (IL-6) levels with disability and mortality in the elderly in the Treviso Longeva (Trelong) study. Arch Gerontol Geriatr 44:193–198. doi:10.1016/j.archger.2007.01.026
Gallucci M, Ongaro F, Bresolin F, Bernardi U, Salvato C, Minello A, Amici GP, Barasciutti E, Mazzuco S, Gajo GB, De Angeli S, Forloni GL, Albani D, Zanardo A, Regini C (2007b) The Treviso Longeva (Trelong) study: a biomedical, demographic, economic and social investigation on people 70 years and over in a typical town of North-East of Italy. Arch Gerontol Geriatr 44:173–192. doi:10.1016/j.archger.2007.01.025
Giacconi R, Cipriano C, Albanese F, Boccoli G, Saba V, Olivieri F, Franceschi C, Mocchegiani E (2004) The -174G/C polymorphism of IL-6 is useful to screen old subjects at risk for atherosclerosis or to reach successful ageing. Exp Gerontol 39:621–628. doi:10.1016/j.exger.2003.12.013
Gruenewald TL, Seeman TE, Ryff CD, Karlamangla AS, Singer BH (2006) Combinations of biomarkers predictive of later life mortality. Proc Natl Acad Sci USA 103:14158–14163. doi:10.1073/pnas.0606215103
Hefler LA, Grimm C, Lantzsch T, Lampe D, Leodolter S, Koelbl H, Heinze G, Reinthaller A, Tong-Cacsire D, Tempfer C, Zeillinger R (2005) Interleukin-1 and interleukin-6 gene polymorphisms and the risk of breast cancer in caucasian women. Clin Cancer Res 11:5718–5721. doi:10.1158/1078-0432.CCR-05-0001
Herndon LA, Schmeissner PJ, Dudaronek JM, Brown PA, Listner KM, Sakano Y, Paupard MC, Hall DH, Driscoll M (2002) Stochastic and genetic factors influence tissue-specific decline in ageing C. elegans. Nature 419:808–814. doi:10.1038/nature01135
Herskind A, McGue M, Holm N, Sørensen T, Harvald B, Vaupel J (1996) The heritability of human longevity: a population-based study of 2872 Danish twin pairs born 1870-1900. Hum Genet 97:319–323. doi:10.1007/BF02185763
Hurme M, Lehtimäki T, Jylhä M, Karhunen PJ, Hervonen A (2005) Interleukin-6-174G/C polymorphism and longevity: a follow-up study. Mech Ageing Dev 126:417–418. doi:10.1016/j.mad.2004.10.001
Jylhä M, Paavilainen P, Lehtimäki T, Goebeler S, Karhunen PJ, Hervonen A, Hurme M (2007) Interleukin-1 receptor antagonist, interleukin-6, and C-reactive protein as predictors of mortality in nonagenarians: the vitality 90 + study. J Gerontol A Biol Sci Med Sci 62:1016–1021
Kim SK (2007) Common aging pathways in worms, flies, mice and humans. J Exp Biol 210:1607–1612. doi:10.1242/jeb.004887
Lio D, Scola L, Crivello A, Colonna-Romano G, Candore G, Bonafè M, Cavallone L, Franceschi C, Caruso C (2002) Gender-specific association between -1082 IL-10 promoter polymorphism and longevity. Genes Immun 3:30–33. doi:10.1038/sj.gene.6363827
Lubrano V, Cocci F, Battaglia D, Papa A, Marraccini P, Zucchelli GC (2005) Usefulness of high-sensitivity IL-6 measurement for clinical characterization of patients with coronary artery disease. J Clin Lab Anal 19:110–114. doi:10.1002/jcla.20061
Mastorakos G, Ilias I (2006) Interleukin-6: a cytokine and/or a major modulator of the response to somatic stress. Ann N Y Acad Sci 1088:373–381. doi:10.1196/annals.1366.021
Pes GM, Lio D, Carru C, Deiana L, Baggio G, Franceschi C, Ferrucci L, Oliveri F, Scola L, Crivello A, Candore G, Colonna-Romano G, Caruso C (2004) Association between longevity and cytokine gene polymorphisms. A study in Sardinian centenarians. Aging Clin Exp Res 16:244–248
Sawczenko A, Azooz O, Paraszczuk J, Idestrom M, Croft NM, Savage MO, Ballinger AB, Sanderson IR (2005) Intestinal inflammation-induced growth retardation acts through IL-6 in rats and depends on the -174 IL-6 G/C polymorphism in children. Proc Natl Acad Sci USA 102:13260–13265. doi:10.1073/pnas.0503589102
Van Bodegom D, May L, Meij HJ, Westendorp RG (2007) Regulation of human life histories: the role of the inflammatory host response. Ann N Y Acad Sci 1100:84–97. doi:10.1196/annals.1395.007
vB Hjelmborg J, Iachine I, Skytthe A, Vaupel JW, McGue M, Koskenvuo M, Kaprio J, Pedersen NL, Christensen K (2006) Genetic influence on human lifespan and longevity. Hum Genet 119:312–321
Acknowledgements
This study was supported by grants from the Veneto Region, the Treviso Municipality, Treviso Province and Cassamarca Foundation. The support of Monzino Foundation (Milan, Italy) and “Centro Dino Ferrari” (Milan, Italy) is also acknowledged. We are grateful to all patients who kindly agreed to participate in this study and to J.D. Baggott for manuscript editing. L.P. is recipient of a fellowship from “Golgi Cenci Foundation”, Milan, Italy.
Author information
Authors and Affiliations
Corresponding author
About this article
Cite this article
Albani, D., Batelli, S., Polito, L. et al. Interleukin-6 plasma level increases with age in an Italian elderly population (“The Treviso Longeva”–Trelong–study) with a sex-specific contribution of rs1800795 polymorphism. AGE 31, 155–162 (2009). https://doi.org/10.1007/s11357-009-9092-5
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s11357-009-9092-5